The Blood Group Typing Market is moving toward faster, more automated, and increasingly precise transfusion testing. Market Research Future estimates that the industry will grow from USD 2.41 billion in 2025 to USD 5.31 billion by 2035, with a CAGR of 8.2% during 2026–2035.

ABO blood testing remains the most frequently performed category, accounting for 37.8% of the market in 2025. However, expanded antigen typing is gaining importance because patients receiving repeated transfusions may require more detailed matching to support safe and effective transfusion management.

The market is also benefiting from advances in molecular diagnostics. PCR-based and microarray technologies support extended genotyping, while next-generation sequencing is expected to record strong growth as laboratories address complex blood-group variants and increasingly personalized transfusion requirements.

Hospitals represented 48.2% of end-user revenue in 2025, while diagnostic laboratories are projected to experience faster growth. North America currently leads the regional landscape, and Asia-Pacific is emerging as a high-growth market as blood-safety initiatives and healthcare infrastructure continue to develop.

Looking ahead, AI-integrated interpretation, point-of-care blood typing, automated blood-bank workflows, and digital donor registries could reshape the industry. These technologies may improve turnaround times, reduce manual workload, and support more comprehensive blood-group information for complex clinical cases.

Discover emerging opportunities with in-depth research reports:

Pharmaceutical Solvent Market Outlook

Pedicle Screw Systems Market Analysis

Robotic Flight Simulator Surgery Market Distribution

Patient Experience Technology Market Size

Bone Biopsy Market Share